Loading…
Olympus Corporation agreed to acquire Taewoong Medical Co., Ltd., a Korean manufacturer of gastrointestinal metallic stents, for approximately $370 million in cash, with $255.5 million paid at closing and up to $114.5 million in milestone payments. The transaction is expected to close on June 30, 2023.